Advances in Chronic Kidney Disease
Latest Publications

TOTAL DOCUMENTS

1604

(FIVE YEARS 277)

H-INDEX

(FIVE YEARS 7)

Published By Elsevier - Wb Saunders

1548-5595

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2021.02.001 ◽

2021 ◽

Vol 28 (4) ◽

pp. 318-327

Author(s):

Joshua J. Neumiller ◽

Radica Z. Alicic ◽

Katherine R. Tuttle

Keyword(s):

Kidney Disease ◽

Diabetic Kidney Disease ◽

Lessons Learned ◽

Diabetic Kidney ◽

New Therapies

Download Full-text

What Have We Learned so Far From the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Clinical Practice?

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2021.06.002 ◽

2021 ◽

Vol 28 (4) ◽

pp. 290-297

Author(s):

Peter Rossing ◽

Frederik Persson

Keyword(s):

Clinical Practice ◽

Sodium Glucose Cotransporter

Download Full-text

Novel Glucose-Lowering Therapies in the Setting of Solid Organ Transplantation

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2021.03.001 ◽

2021 ◽

Vol 28 (4) ◽

pp. 361-370

Author(s):

Pitchaphon Nissaisorakarn ◽

Martha Pavlakis ◽

Amtul Aala

Keyword(s):

Organ Transplantation ◽

Solid Organ Transplantation ◽

Solid Organ ◽

Glucose Lowering

Download Full-text

Novel Anti-inflammatory and Anti-fibrotic Agents for Diabetic Kidney Disease—From Bench to Bedside

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2021.09.010 ◽

2021 ◽

Vol 28 (4) ◽

pp. 378-390

Author(s):

Susanne B. Nicholas

Keyword(s):

Kidney Disease ◽

Diabetic Kidney Disease ◽

Diabetic Kidney ◽

Anti Inflammatory

Download Full-text

Advances in Chronic Kidney Disease ◽

10.1053/s1548-5595(21)00139-7 ◽

2021 ◽

Vol 28 (4) ◽

pp. A4-A5

Download Full-text

Treatment of Diabetic Nephropathy: Changing Landscapes and New Horizons

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2021.11.001 ◽

2021 ◽

Vol 28 (4) ◽

pp. 279

Author(s):

Charuhas V. Thakar

Keyword(s):

Diabetic Nephropathy ◽

New Horizons

Download Full-text

Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2021.04.005 ◽

2021 ◽

Vol 28 (4) ◽

pp. 347-360

Author(s):

Ofri Mosenzon ◽

Meir Schechter ◽

Gil Leibowitz

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

A New Therapeutic Era in the Management of Diabetic Kidney Disease

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2021.11.002 ◽

2021 ◽

Vol 28 (4) ◽

pp. 280-281

Author(s):

Sylvia E. Rosas ◽

David Z.I. Cherney

Keyword(s):

Kidney Disease ◽

Diabetic Kidney Disease ◽

Diabetic Kidney

Download Full-text

NKF 2022 Spring Clinical Meetings Physician Program

Advances in Chronic Kidney Disease ◽

10.1053/s1548-5595(21)00172-5 ◽

2021 ◽

Vol 28 (4) ◽

pp. A8-A13

Download Full-text

Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without Diabetes

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2021.02.006 ◽

2021 ◽

Vol 28 (4) ◽

pp. 298-308

Author(s):

Carol Pollock ◽

Brendon L. Neuen

Keyword(s):

Cardiovascular Protection ◽

Sodium Glucose Cotransporter

Download Full-text

Advances in Chronic Kidney Disease
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier - Wb Saunders

Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned

What Have We Learned so Far From the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Clinical Practice?

Novel Glucose-Lowering Therapies in the Setting of Solid Organ Transplantation

Novel Anti-inflammatory and Anti-fibrotic Agents for Diabetic Kidney Disease—From Bench to Bedside

Table of Contents

Treatment of Diabetic Nephropathy: Changing Landscapes and New Horizons

Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes

A New Therapeutic Era in the Management of Diabetic Kidney Disease

NKF 2022 Spring Clinical Meetings Physician Program

Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without Diabetes

Export Citation Format

Advances in Chronic Kidney DiseaseLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier - Wb Saunders

Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned

What Have We Learned so Far From the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Clinical Practice?

Novel Glucose-Lowering Therapies in the Setting of Solid Organ Transplantation

Novel Anti-inflammatory and Anti-fibrotic Agents for Diabetic Kidney Disease—From Bench to Bedside

Table of Contents

Treatment of Diabetic Nephropathy: Changing Landscapes and New Horizons

Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes

A New Therapeutic Era in the Management of Diabetic Kidney Disease

NKF 2022 Spring Clinical Meetings Physician Program

Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without Diabetes

Advances in Chronic Kidney Disease
Latest Publications